| A randomized study of alglucosidase alfa in late-onset Pompe's disease AT Van der Ploeg, PR Clemens, D Corzo, DM Escolar, J Florence, ... New England Journal of Medicine 362 (15), 1396-1406, 2010 | 773 | 2010 |
| A randomized sequential trial of creatine in amyotrophic lateral sclerosis G Jan Groeneveld, JH Veldink, I van der Tweel, S Kalmijn, C Beijer, ... Annals of Neurology: Official Journal of the American Neurological …, 2003 | 359 | 2003 |
| Physical activity and the association with sporadic ALS JH Veldink, S Kalmijn, GJ Groeneveld, MJ Titulaer, JHJ Wokke, ... Neurology 64 (2), 241-245, 2005 | 181 | 2005 |
| Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis JH Veldink, S Kalmijn, GJ Groeneveld, W Wunderink, A Koster, ... Journal of Neurology, Neurosurgery & Psychiatry 78 (4), 367-371, 2007 | 158 | 2007 |
| SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS JH Veldink, S Kalmijn, AH Van der Hout, HH Lemmink, GJ Groeneveld, ... Neurology 65 (6), 820-825, 2005 | 149 | 2005 |
| PCV chemotherapy for recurrent glioblastoma multiforme AC Kappelle, TJ Postma, MJB Taphoorn, GJ Groeneveld, ... Neurology 56 (1), 118-120, 2001 | 139 | 2001 |
| Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis S Piepers, JH Veldink, SW De Jong, I Van Der Tweel, WL Van Der Pol, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 136 | 2009 |
| Few adverse effects of long-term creatine supplementation in a placebo-controlled trial GJ Groeneveld, C Beijer, JH Veldink, S Kalmijn, JHJ Wokke, ... International journal of sports medicine 26 (04), 307-313, 2005 | 110 | 2005 |
| Effects on spasticity and neuropathic pain of an oral formulation of Δ9-tetrahydrocannabinol in patients with progressive multiple sclerosis G van Amerongen, K Kanhai, AC Baakman, J Heuberger, E Klaassen, ... Clinical therapeutics 40 (9), 1467-1482, 2018 | 90 | 2018 |
| Mitochondrial function is impaired in the skeletal muscle of pre-frail elderly PA Andreux, MPJ Van Diemen, MR Heezen, J Auwerx, C Rinsch, ... Scientific reports 8 (1), 8548, 2018 | 87 | 2018 |
| EEG machine learning for accurate detection of cholinergic intervention and Alzheimer’s disease S Simpraga, R Alvarez-Jimenez, HD Mansvelder, JMA Van Gerven, ... Scientific reports 7 (1), 5775, 2017 | 87 | 2017 |
| The use of biomarkers in human pharmacology (Phase I) studies AF Cohen, J Burggraaf, JMA Van Gerven, M Moerland, GJ Groeneveld Annual review of pharmacology and toxicology 55, 55-74, 2015 | 69 | 2015 |
| Lack of association between VEGF polymorphisms and ALS in a Dutch population PWJ Van Vught, NA Sutedja, JH Veldink, BPC Koeleman, GJ Groeneveld, ... Neurology 65 (10), 1643-1645, 2005 | 69 | 2005 |
| Measuring blood–brain barrier penetration using the NeuroCart, a CNS test battery GJ Groeneveld, JL Hay, JM Van Gerven Drug Discovery Today: Technologies 20, 27-34, 2016 | 68 | 2016 |
| Ovariectomy and 17β-estradiol modulate disease progression of a mouse model of ALS GJ Groeneveld, FL Van Muiswinkel, JM Sturkenboom, JHJ Wokke, ... Brain research 1021 (1), 128-131, 2004 | 68 | 2004 |
| Riluzole serum concentrations in patients with ALS: associations with side effects and symptoms GJ Groeneveld, HJM Van Kan, S Kalmijn, JH Veldink, HJ Guchelaar, ... Neurology 61 (8), 1141-1143, 2003 | 59 | 2003 |
| Respiratory effects of the nociceptin/orphanin FQ peptide and opioid receptor agonist, cebranopadol, in healthy human volunteers A Dahan, M Boom, E Sarton, J Hay, GJ Groeneveld, M Neukirchen, ... Anesthesiology 126 (4), 697-707, 2017 | 56 | 2017 |
| DNL 104, a centrally penetrant RIPK 1 inhibitor, inhibits RIP 1 kinase phosphorylation in a randomized phase I ascending dose study in healthy volunteers HW Grievink, JAAC Heuberger, F Huang, R Chaudhary, WAJ Birkhoff, ... Clinical Pharmacology & Therapeutics 107 (2), 406-414, 2020 | 53 | 2020 |
| A Large‐Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands JM den Heijer, VC Cullen, M Quadri, A Schmitz, DC Hilt, P Lansbury, ... Movement Disorders 35 (9), 1667-1674, 2020 | 47 | 2020 |
| Fentanyl utility function: a risk–benefit composite of pain relief and breathing responses M Boom, E Olofsen, M Neukirchen, R Fussen, J Hay, G Jan Groeneveld, ... Anesthesiology 119 (3), 663-674, 2013 | 47 | 2013 |
